$
1.100
-0.02(-1.786%)1D
  • Overview
  • Forecast
  • Valuation
  • Earnings
Line
Line
|
Candle
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
1.110
Open
0.9699
VWAP
0.98
Vol
695.95K
Mkt Cap
2.75M
Low
0.900
Amount
679.01K
EV/EBITDA(TTM)
--
Total Shares
13.08M
EV
2.01M
EV/OCF(TTM)
--
P/S(TTM)
0.16
iSpecimen Inc. is a technology-driven company. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company’s iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. Its technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. In addition to providing the technology platform to connect researchers and healthcare providers, the Company handles all marketing, sales, contracting, and compliance functions across both sides of the marketplace. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data and administrative, compliance and reporting.
Show More

Market Estimates

Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q1
FY2024Q4
FY2024Q3
2.55M
+11.18%
--
--
2.98M
+15.61%
--
--
2.95M
+6.09%
--
--
Estimates Revision
The market is revising No Change the revenue expectations for iSpecimen Inc. (ISPC) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by -9.47%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Down
down Image
-9.47%
In Past 3 Month

Valuation Metrics

The current forward P/E ratio for iSpecimen Inc (ISPC.O) is -0.07, compared to its 5-year average forward P/E of -14.99. For a more detailed relative valuation and DCF analysis to assess iSpecimen Inc 's fair value, click here.

Forward PE

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-14.99
Current PE
-0.07
Overvalued PE
42.64
Undervalued PE
-72.61

Forward EV/EBITDA

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-1.57
Current EV/EBITDA
-0.31
Overvalued EV/EBITDA
2.34
Undervalued EV/EBITDA
-5.47

Forward PS

StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.55
Current PS
0.21
Overvalued PS
3.42
Undervalued PS
-0.32

Financials

Annual
Quarterly
FY2025Q1
YoY :
-53.82%
1.06M
Total Revenue
FY2025Q1
YoY :
-45.40%
-1.64M
Operating Profit
FY2025Q1
YoY :
-42.86%
-1.66M
Net Income after Tax
FY2025Q1
YoY :
-88.84%
-0.71
EPS - Diluted
FY2025Q1
YoY :
-100.00%
N/A
Free Cash Flow
FY2025Q1
YoY :
-32.81%
37.85
Gross Profit Margin - %
FY2025Q1
YoY :
-100.00%
N/A
FCF Margin - %
FY2025Q1
YoY :
+23.74%
-156.82
Net Margin - %

Trading Trends

Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months

ISPC News & Events

Events Timeline

2025-07-24 (ET)
2025-07-24
08:41:24
iSpecimen prices 5.7M shares at 70c in underwritten public offering
select
2024-11-07 (ET)
2024-11-07
06:49:54
iSpecimen releases cancer biospecimen offering
select
2024-11-07
06:10:18
iSpecimen reports Q3 EPS ($2.10) vs ($4.66) last year
select
Sign Up For More Events

News

4.5
01-17Benzinga
US Stock Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst
5.0
01-17Benzinga
US Stocks Likely To Open Higher Ahead of Trump's Inaugration: All 11 Sectors To Report Growing Profits In 2025, Says Analyst
2.0
01-17Benzinga
Why Versus Systems Shares Are Trading Higher By Around 71%; Here Are 20 Stocks Moving Premarket
Sign Up For More News

FAQ

arrow icon

What is iSpecimen Inc (ISPC) stock price today?

The current price of ISPC is 1.1 USD — it has decreased -1.79 % in the last trading day.

arrow icon

What is iSpecimen Inc (ISPC)'s business?

arrow icon

What is the price predicton of ISPC Stock?

arrow icon

What is iSpecimen Inc (ISPC)'s revenue for the last quarter?

arrow icon

What is iSpecimen Inc (ISPC)'s earnings per share (EPS) for the last quarter?

arrow icon

What changes have occurred in the market's expectations for iSpecimen Inc (ISPC)'s fundamentals?

arrow icon

How many employees does iSpecimen Inc (ISPC). have?

arrow icon

What is iSpecimen Inc (ISPC) market cap?